Skip to content
Bored Studies
RecruitingPhase 1

Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar Pain

R3 Stem Cell · with R3 Medical Research · NCT06361485

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 20+ · All sexes
Healthy volunteers
Not accepted (a condition is required)
Study type
Interventional · Phase 1
Target enrollment
100
US sites recruiting
4
Study start
March 25, 2024
Record last updated
April 11, 2024

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This is a Pilot Study that is an open label, prospective, non-controlled study in which the safety and feasibility of Wharton's Jelly (WJ) allograft will be evaluated in 100 participants suffering with low back pain.

Being studied: Lumbar Injections with 10cc's of Wharton's Jelly Allograft

Conditions: Low Back Pain

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Patient must
  • Be over age 20.
  • Suffering from chronic lumbar pain
  • Body Mass Index (BMI) \<50 Kilograms/m2.
  • Pain score of 4 or more on the Numeric Pain Rating Scale (NPRS).
  • Female participants must be abstinent, surgically sterilized or postmenopausal.
  • Premenopausal females must be on contraceptive measures and do not anticipate pregnancy during the duration of the study.
  • Be willing and capable of giving written informed consent to participate in English.
  • Be willing and capable of complying with study-related requirements, procedures and visits.

Exclusion Criteria

  • Patient must not
  • Have taken any pain medication including nonsteroidal anti-inflammatory drugs (NSAIDs) within 2 weeks prior to study injection date.
  • Use anticoagulants have a substance abuse history, and fail to agree not to take any lumbar symptom modifying drugs during the course of the study without discussing and reporting the use to the site Clinical investigator and study team.
  • Known allergy to penicillin, sulfa or amphotericin medications.
  • Have had any lumbar injections (at all) of any drug in lumbar spine in the past 6 months.
  • Have had surgery on the lumbar spine within the past 6 months.
  • Had a traumatic injury to the lumbar spine with the past 3 months.
  • Planned elective surgery during the course of the study.
  • A history of organ or hematologic transplantation, rheumatoid arthritis, or other autoimmune disorders.
  • Be on immunosuppressive medications.
  • Have a diagnosis of carcinoma with the past 5 years.
  • Have a lumbar infection or have used antibiotics for lumbar infection within the past 3 months.
  • Have participated in any other clinical study or treatment (not just for the lumbar spine, but for any reason) with any investigational product within the past 30 days prior to inclusion of study.
  • Female participants who are breast feeding or are pregnant or desire to become pregnant during the course of the study.
  • Contraindications to radiographic or MRI imaging.
  • Serious neurological, psychological or psychiatric disorders.
  • Injury or disability claims under current litigation or pending or approved workers compensation claims.

Recruiting US locations

  • R3 Anti Aging Scottsdale

    Scottsdale, AZ 85262

    Site contact: David Greene, MD, PhD, MBA · 480-306-6256 · dgreene@r3medicalresearch.com

  • R3 Anti Aging Beverly Hills

    Beverly Hills, CA 90210

    Site contact: Kathleen Francesca, BA · 424-382-1074 · kfrancesca@r3stemcell.com

  • Scheer Medical Wellness

    New York, NY 10036

    Site contact: Alexandre Scheer, MD · 646-762-9499 · ascheer911@gmail.com

  • Dr. Duc (Steve) Le, MD

    Cleveland, TX 77327

    Site contact: Steve Le, MD · 281-593-1500 · ducstevele@gmail.com

Study contacts (from the official record)

  • David L Greene, MD, PhD, MBA · (602) 677-8981 · dgreene@r3medicalresearch.com
  • Katherine Minter-Dykhouse, PhD · 4803066256 · kmd@bello.bio
All arthritis studies in Arizona →
Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft… (NCT06361485) | Bored Studies